Platelet survival in patients with substitute heart valves.
D000244:Adenosine Diphosphate; D001021:Aortic Valve / Q000601:surgery; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology*; D002470:Cell Survival; D002860:Chromium Radioisotopes; D003094:Collagen; D006349:Heart Valve Diseases / Q000150:complications; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006351:Heart Valves / Q000637:transplantation; D006801:Humans; D008943:Mitral Valve / Q000601:surgery; D010973:Platelet Adhesiveness; D011183:Postoperative Complications; D011379:Prognosis; D011474:Prosthesis Design; D013442:Sulfinpyrazone / Q000494:pharmacology / Q000627:therapeutic use; D013923:Thromboembolism / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology*; D013997:Time Factors; D014184:Transplantation, Homologous; D014859:Warfarin / Q000494:pharmacology / Q000627:therapeutic use
D002860:Chromium Radioisotopes; D014859:Warfarin; D000244:Adenosine Diphosphate; D003094:Collagen; D013442:Sulfinpyrazone